Novartis AG Profit Margin

As of the most recent data (September 2026), NVSEF shows a profit margin of 17.89%. That compares with 25.63% in the prior-year period — down 30.2% year over year. That is above the Healthcare sector average of 17.63%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NVSEF's profit margin is now 17.89% (was 25.63%) — a 30.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Novartis AG is outperforming or lagging.

The Healthcare sector average profit margin is about 17.63%. Novartis AG is at 17.89%, which is higher that average. That is roughly 1.5% above the sector mean. Use the comparison chart on this page to see how NVSEF stacks up against individual peers as well.

That compares with 25.63% in the prior-year period — down 30.2% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Novartis AG with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Novartis AG's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 17.89%) with ownership activity and broader fundamentals.